{
  "schemaVersion": 1,
  "id": "research-175",
  "slug": "175-why-different-hcg-medicines-have-different-labeled-uses",
  "title": "Why different hCG medicines have different labeled uses",
  "catalogLabel": "HCG",
  "productCollection": "https://heritagebiolabs.com/research-library/products/hcg",
  "productHandles": [
    "hcg-683"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/hcg-683"
  ],
  "readingFocus": "Methods & identity",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 319,
  "sourceYears": [
    2021,
    2023,
    2025
  ],
  "paragraphs": [
    "Short chains of amino acids joined by peptide bonds can serve as hormone signals. Human chorionic gonadotropin, abbreviated hCG, is a larger glycoprotein with two amino-acid chains and attached sugars. It acts at a receptor that also recognizes luteinizing hormone. The U.S. prescribing information for two hCG products shows why the general name and a particular approved product convey different information. [1, 2]",
    "Pregnyl is a preparation of chorionic gonadotropin obtained from human pregnancy urine. Its U.S. label lists ovulation induction in specified infertility circumstances, selected cases of male hypogonadotropic hypogonadism and certain cases of prepubertal undescended testes without an anatomical obstruction. Ovidrel contains recombinant choriogonadotropin alfa, meaning it is produced using cells engineered to make the hormone. Its label describes use for final follicular maturation and early luteinization in patients undergoing assisted reproduction, and for ovulation induction in defined patients. [1, 2]",
    "The receptor explains the shared thread among some of these uses. In the ovary, the luteinizing-hormone signal plays a role in final egg maturation and ovulation. In the testes, activation of the receptor can stimulate androgen production by Leydig cells. An older structural study used cryo-electron microscopy to examine how hCG binds and activates the receptor. The molecular image describes a physical interaction. Its relevance to a particular condition or product is established separately by clinical and regulatory evidence. [1, 2, 3]",
    "The labels also describe risks tied to the use being studied or approved. In ovarian stimulation, one of those risks is ovarian hyperstimulation syndrome, an excessive response to the hormonal stimulation. The label for Pregnyl states that evidence does not support hCG as a treatment for obesity. The two approved medicines have their own product descriptions, indications and warnings. The older structural work and the product labels are the sources for these specific questions, while newer clinical trials tend to compare defined fertility approaches rather than revisiting what the labels cover. [1, 2, 3]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "Organon. Pregnyl (chorionic gonadotropin) for injection. U.S. prescribing information on DailyMed (revision 2025-03).",
      "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e94155f-19be-4944-b197-be4edbb4faf9"
    },
    {
      "number": 2,
      "citation": "EMD Serono. OVIDREL- choriogonadotropin alfa injection, solution. U.S. prescribing information on DailyMed (updated 2023-12-26).",
      "url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a683e58a-63ea-44b8-a326-1a99a537bcf2"
    },
    {
      "number": 3,
      "citation": "Duan J et al. Structures of full-length glycoprotein hormone receptor signalling complexes. Nature (publication 2021-09-22).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/34552239/"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/175-why-different-hcg-medicines-have-different-labeled-uses",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/175-why-different-hcg-medicines-have-different-labeled-uses.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/175-why-different-hcg-medicines-have-different-labeled-uses.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 035 - HCG.docx",
    "sourceArticleNumber": 175,
    "contentSha256": "27315ff7cf800ca5ece843f53852f0446323108516a0ec51b15020cf6511a761",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
